ASLAN Pharmaceuticals Appoints Kenneth Kobayashi, MD, as Chief Medical Officer
03 août 2020 03h17 HE
|
ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, Aug. 03, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative...